ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

IMAB I MAB

1.84
-0.02 (-1.08%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
I MAB NASDAQ:IMAB NASDAQ Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  -0.02 -1.08% 1.84 1.66 3.73 1.86 1.83 1.85 98,437 21:25:00

I-Mab to Participate at the Jefferies Global Healthcare Conference

22/05/2024 12:00pm

PR Newswire (US)


I MAB (NASDAQ:IMAB)
Historical Stock Chart


From Jun 2024 to Jun 2024

Click Here for more I MAB Charts.

ROCKVILLE, Md., May 22, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB), a U.S.-based global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced that management will present at the Jefferies Global Healthcare Conference on June 5, 2024.

(PRNewsfoto/I-Mab Biopharma)

Jefferies Global Healthcare Conference

Presentation Time

Wednesday, June 5 at 9:30 a.m. EST

Presenters

Raj Kannan, CEO; Louie Naumovski, Interim CMO

Webcast link

Here

Meetings

One-on-one and small group meetings: June 5, 2024

Management
Participants

Raj Kannan, CEO

Joe Skelton, CFO

Louie Naumovski, Interim CMO

Tyler Ehler, Senior Director, Investor Relations

The webcast will also be available under "Event Calendar" on I-Mab's IR website
at https://ir.i-mabbiopharma.com/

For more information, please contact your Jefferies representative.

About I-Mab

I-Mab (NASDAQ: IMAB) is a U.S.-based global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer. I-Mab has established operations in Rockville, Maryland, and in San Diego, California. For more information, please visit  https://ir.i-mabbiopharma.com/ and follow us on LinkedIn and X.

For more information, please contact:
Tyler Ehler
Senior Director, Investor Relations
IR@imabbio.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/i-mab-to-participate-at-the-jefferies-global-healthcare-conference-302150438.html

SOURCE I-Mab Biopharma

Copyright 2024 PR Newswire

1 Year I MAB Chart

1 Year I MAB Chart

1 Month I MAB Chart

1 Month I MAB Chart

Your Recent History

Delayed Upgrade Clock